期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
Background: Evidence for the choice of second line, standard vs high dose chemotherapy, (SDCT, HDCT) for patients with relapsed germ cell tumors (GCTs......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 172 ()
The most widespread, malignant, and deadliest type of glial tumor is glioblastoma multiforme (GBM). Despite radiation, chemotherapy, and radical surge......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
This systematic review and meta-analysis evaluated the prognostic role of cell-free DNA (cfDNA) in pancreatic ductal adenocarcinoma (PDAC). Eligible s......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
During the last decade, major improvements have been made in the treatment of renal cell carcinoma (RCC) with the development and use of multiple tyro......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 175 ()
Drug repositioning in cancer has been pursued for years because of slowing drug development, increasing costs, and the availability of drugs licensed ......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()
Examining and addressing unmet care needs is integral to improving the provision and quality of cancer services. This review explored the prevalence o......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
We report on the third Assisi Think Tank Meeting (ATTM) on breast cancer, a brainstorming project which involved European radiation and clinical oncol......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 178 ()
The activation of innate immune response after the engagement of dsDNA is an evolutionarily preserved so-phisticated strategy against invading microbi......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
Introduction: Although salvage surgery (SS) is considered the best curative choice in recurrent head and neck cancer, the identification of patients w......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
Lung cancer organoids (LCOs) have sprung up in more and more researching fields, because of their ability to recapitulate the three-dimensional struct......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 171 ()
Therapy-related acute myeloid leukemia (t-AML), defined as AML arising from prior cytotoxic, radiation, or immunosuppressive therapy for an unrelated ......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 173 ()
To summarize randomized controlled trials (RCTs) evidence for the effectiveness of available treatment strategies for elderly patients with glioblasto......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 177 ()
Acute myelogenous leukemia (AML) is a genetically heterogeneous and aggressive cancer of the Hematopoietic Stem/progenitor cells. It is distinguished ......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 176 ()
Statins are commonly prescribed to reduce plasma cholesterol levels and risk of cardiovascular events and mortality. Statin exposure may have cancer-p......
期刊： CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022; 169 ()
We present the current clinical applications of radiomics in the context of prostate cancer (PCa) management. Several online databases for original ar......
